• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Saturday 10/20/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Sklyline Medical

  • 2:20 PM

    Recent News – – – – – Company appoints Jean-Paul Rasschaert as Vice President of International Sales MINNEAPOLIS, Jan. 26, 2018 (GLOBE NEWSWIRE) — Skyline Medical Inc (NASDAQ:SKLN) (“Skyline” or the “Company”), today announced that it has opened new European headquarters in Belgium and appointed Jean-Paul Rasschaert as Vice President of International Sales to drive international sales for the STREAMWAY System. Based in Brussels, Mr. Rasschaert will be responsible for overseeing sales of the Company’s FDA-approved STREAMWAY® System for automated, direct-to-drain medical

    Read more
  • 2:08 PM

    JERUSALEM, June 11, 2015 /PRNewswire/ –Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), a developer of oral drug delivery systems, today announced the closing of its previously-announced registered direct placement with institutional investors. Oramed has sold $5.36 million of shares of common stock at $7.50 per share. Investors have also received an oversubscription option to purchase up to an additional $7.1 million of common stock at $10.00 per share that becomes exercisable six months from today and is exercisable for twelve months. H.C. Wainwright & Co. acted as the exclusive placement agent for the

    Read more
  • 2:08 PM

    SAN DIEGO, June 3, 2015 /PRNewswire/ — OncoSec Medical Inc. (“OncoSec”) (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that it has entered into definitive agreements with dedicated healthcare institutional investors to purchase approximately $13.6 million of securities in a registered direct offering. OncoSec has agreed to sell to such investors an aggregate of 2,469,091 shares of its common stock at a price of $5.50 per share. The gross proceeds of the offering are approximately $13.6 million. Net proceeds, after deducting the placement agent’s fee and

    Read more
Public Wire Banner